Risk factors of treatment failure and 30-day mortality in patients with bacteremia due to MRSA with reduced vancomycin susceptibility
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Risk factors of treatment failure and 30-day mortality in patients with bacteremia due to MRSA with reduced vancomycin susceptibility ; volume:8 ; number:1 ; day:18 ; month:5 ; year:2018 ; pages:1-7 ; date:12.2018
Scientific reports ; 8, Heft 1 (18.5.2018), 1-7, 12.2018
- Urheber
-
Yang, Chien-Chang
- Beteiligte Personen und Organisationen
-
Sy, Cheng-Len
Huang, Yhu-Chering
Shie, Shian-Sen
Shu, Jwu-Ching
Hsieh, Pang-Hsin
Hsiao, Ching-Hsi
Chen, Chih-Jung
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-26277-9
- URN
-
urn:nbn:de:101:1-2018071717123472537927
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yang, Chien-Chang
- Sy, Cheng-Len
- Huang, Yhu-Chering
- Shie, Shian-Sen
- Shu, Jwu-Ching
- Hsieh, Pang-Hsin
- Hsiao, Ching-Hsi
- Chen, Chih-Jung
- SpringerLink (Online service)
Ähnliche Objekte (12)
Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It’s Complicated
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
Therapeutic Dose Monitoring for Linezolid in a Patient with MRSA Pneumonia with Bacteremia in Diabetes Insipidus
Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
Multifunctional lipid-based nanocarriers with antibacterial and anti‐inflammatory activities for treating MRSA bacteremia in mice
Usefulness of daptomycin lock therapy in children with catheter-related bacteremia after failed vancomycin lock therapy
Epidemiology of clinically isolated methicillin-resistant Staphylococcus aureus (MRSA) and its susceptibility to linezolid and vancomycin in Egypt: a systematic review with meta-analysis
Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia
Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
Potent Rifampicin derivatives can clear MRSA infections at single low doses when concomitantly dosed with Vancomycin
Association of vancomycin trough concentration on the treatment outcome of patients with bacteremia caused by Enterococcus species
Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It’s Complicated
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
Therapeutic Dose Monitoring for Linezolid in a Patient with MRSA Pneumonia with Bacteremia in Diabetes Insipidus
Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
Multifunctional lipid-based nanocarriers with antibacterial and anti‐inflammatory activities for treating MRSA bacteremia in mice
Usefulness of daptomycin lock therapy in children with catheter-related bacteremia after failed vancomycin lock therapy
Epidemiology of clinically isolated methicillin-resistant Staphylococcus aureus (MRSA) and its susceptibility to linezolid and vancomycin in Egypt: a systematic review with meta-analysis
Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia
Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
Potent Rifampicin derivatives can clear MRSA infections at single low doses when concomitantly dosed with Vancomycin
Association of vancomycin trough concentration on the treatment outcome of patients with bacteremia caused by Enterococcus species
Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It’s Complicated
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
Therapeutic Dose Monitoring for Linezolid in a Patient with MRSA Pneumonia with Bacteremia in Diabetes Insipidus
Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
Multifunctional lipid-based nanocarriers with antibacterial and anti‐inflammatory activities for treating MRSA bacteremia in mice
Usefulness of daptomycin lock therapy in children with catheter-related bacteremia after failed vancomycin lock therapy
Epidemiology of clinically isolated methicillin-resistant Staphylococcus aureus (MRSA) and its susceptibility to linezolid and vancomycin in Egypt: a systematic review with meta-analysis
Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia
Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
Potent Rifampicin derivatives can clear MRSA infections at single low doses when concomitantly dosed with Vancomycin